Matthew Hamilton and Claire Hughes are reporting at Capitol Confidential the state Health Department announced Wed., Jan. 20, that children and young adults with epilepsy may qualify for investigational studies of the medication Epidiolex, which contains an ingredient found in marijuana. The study will take place in five locations -- three in New York City, one in Rochester and one in Buffalo. Patients aged 1 to 21, who are not responding to conventional anti-epileptic therapy, will be given access to the drug, which has shown promise in previous studies, Health Commissioner Howard Zucker said. Initial enrollment of patients is expected to begin in the next few months. The studies will last a year. Information on the selection criteria and process will be available online at wadsworth [dot] org. Read the full story at Capitol Confidential, a Times Union blog.